Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2020-07-17 Earnings Release
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Szacunkowe wyniki drugiego kwartału 2020 r. - Content (PL)
Earnings Release Classification · 100% confidence The document text is very short (904 characters) and presents preliminary, estimated financial figures (revenue, EBITDA, net profit) for the second quarter of 2020, comparing them to previous periods. It explicitly states that the consolidated financial statement is being prepared and that the publication of the consolidated report for the first half of 2020 is expected on September 15, 2020. Because this is an initial announcement of key financial highlights for a period (Q2/H1) and not the full, audited report, it fits the definition of an Earnings Release (ER). It is not a full report (10-K or IR) nor is it a mere announcement of a future report's publication (RPA), as it contains the actual preliminary results. Q2 2020
2020-07-17 Polish
Zawarcie i zmiana znaczących umów - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document is written in Polish and discusses an update regarding contracts ('umów') entered into by a subsidiary (MMT) with a US entity (Ammex). The update concerns an increase in the total value of existing contracts and the signing of new supply contracts for gloves. Crucially, the text states that the total value of new contracts and increases exceeded 10% of the consolidated sales revenue for the last four rolling quarters. This type of material transaction disclosure, especially when crossing a significant threshold (like 10% of revenue), is typically classified as a significant event disclosure. Since it is not a standard annual report (10-K), earnings release (ER), or dividend notice (DIV), and it relates to a material transaction/contractual change, it fits best under the general 'Regulatory Filings' category (RNS) as a specific, material, non-standard announcement, or potentially a Capital/Financing Update (CAP) if the contracts were financing-related, but here they are supply contracts. Given the nature of reporting material changes in business agreements that cross revenue thresholds, RNS (Regulatory Filings) is the most appropriate general category for non-standard, mandatory disclosures in this context, as it is a 'raport bieżący' (current report). The document length is short, but it contains the substance of the disclosure, not just an announcement of a report's availability.
2020-07-06 Polish
Zawarcie znaczących umów - Content (PL)
Regulatory Filings Classification · 95% confidence The document is written in Polish and discusses the conclusion of supply agreements by a subsidiary (MMT) of the Issuer (Mercator Medical S.A.). It details the counterparties (Unispace Health Pty Limited and Unispace Health Limited), the total value of the contracts (in PLN), and mentions that the value exceeds 10% of the consolidated sales revenue for the last four reporting quarters. This type of disclosure, concerning significant contracts or transactions, is typical for regulatory filings in many jurisdictions, often falling under material event reporting. Since the text describes the substance of a significant transaction rather than announcing the release of a standard periodic report (like 10-K or IR), and it doesn't fit specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), it is best classified as a general Regulatory Filing (RNS), which serves as the catch-all for material, non-standard announcements.
2020-07-06 Polish
Powiadomienie
Director's Dealing Classification · 98% confidence The document is a formal notification ('Zawińomienie') addressed to the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego) regarding a change in the total number of votes held by an individual/entity in Mercator Medical SA. It explicitly references Article 69 of the Polish Act on Public Offering (Ustawa o ofercie publicznej), which governs major shareholding notifications when thresholds (like 5%, 10%, etc.) are crossed. The content details the 'before' and 'after' shareholding percentages and the number of votes, specifically mentioning the acquisition of own shares by the Issuer (Emitent). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to code MRQ in the provided schema.
2020-06-19 Polish
Znaczne pakiety akcji - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is very short (269 characters) and states that the Management Board of Mercator Medical S.A. received a notification on June 19, 2020, regarding a change in the share of votes held by Mr. Wiesław Żyznowski, and that the content of the notification is attached ('Emitent przekazuje w załączeniu'). This structure—a brief announcement stating that a formal notification regarding shareholding changes has been received and is attached—strongly suggests a notification of a change in significant share ownership crossing a threshold, which corresponds to the Major Shareholding Notification (MRQ) definition. Although it could potentially be RNS, MRQ is more specific for shareholding changes.
2020-06-19 Polish
Powiadomienie
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a formal notification ('Zawiadomienie') submitted to the Polish Financial Supervision Authority ('Komisja Nadzoru Finansowego') by Anabaza Limited regarding a change in its total voting rights in Mercator Medical SA. The notification explicitly references Polish law articles concerning public offerings and shareholder thresholds (art. 69 Ustawy o ofercie publicznej). The content details the change in shareholding percentage (crossing the 1% threshold) due to the Issuer (Mercator Medical SA) acquiring its own shares. This type of mandatory disclosure concerning changes in significant share ownership thresholds is classified as a Major Shareholding Notification.
2020-06-19 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.